title: Comment on thalidomide usage in myeloma.
authors.affiliation: Department of Haematology, Queen's Medical Centre, University Hospital, Lenton Boulevard, Nottingham, NG7 2UH, UK. bmyers@hospital-doctor.net
authors.forename: B
authors.initials: B
authors.lastname: Myers
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D018570:Risk Assessment; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide